drugset / Trial / NCT06209138

5-fluorouracil for Treatment of Stable Vitiligo

NCT06209138

Completed 40 enrolled Al-Azhar University
RandomizedParallel-groupOpen-labelTreatment

Summary

Vitiligo, a significant dermatologic challenge affecting 0.5 to 2% of the global population. Despite various existing medical approaches, current vitiligo treatments are still far from optimal.

Timeline

Start
2024-01-23
Primary completion
2024-04-15
Completion
2024-04-15

Drugs

EvaluationDrugModalityDoseRoute
Subject fluorouracil Small molecule

Indications